135 related articles for article (PubMed ID: 20939684)
1. Methods for synthesis and uses of inhibitors of ghrelin O-acyltransferase inhibitors as potential therapeutic agents for obesity and diabetes.
Costantino L
Expert Opin Ther Pat; 2010 Nov; 20(11):1603-7. PubMed ID: 20939684
[TBL] [Abstract][Full Text] [Related]
2. Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor.
Barnett BP; Hwang Y; Taylor MS; Kirchner H; Pfluger PT; Bernard V; Lin YY; Bowers EM; Mukherjee C; Song WJ; Longo PA; Leahy DJ; Hussain MA; Tschöp MH; Boeke JD; Cole PA
Science; 2010 Dec; 330(6011):1689-92. PubMed ID: 21097901
[TBL] [Abstract][Full Text] [Related]
3. Ghrelin O-acyltransferase assays and inhibition.
Taylor MS; Hwang Y; Hsiao PY; Boeke JD; Cole PA
Methods Enzymol; 2012; 514():205-28. PubMed ID: 22975055
[TBL] [Abstract][Full Text] [Related]
4. DGAT: novel therapeutic target for obesity and type 2 diabetes mellitus.
Subauste A; Burant CF
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):263-70. PubMed ID: 14683457
[TBL] [Abstract][Full Text] [Related]
5. An overview of ghrelin
Moose JE; Leets KA; Mate NA; Chisholm JD; Hougland JL
Expert Opin Ther Pat; 2020 Aug; 30(8):581-593. PubMed ID: 32564644
[TBL] [Abstract][Full Text] [Related]
6. The effect of ghrelin O-acyltransferase inhibitor on gastric H
Du GM; Luo BP; Hu ZH; Wu JG; Yan WM; Han ZQ; Zhang YH; Liu MJ
Gen Comp Endocrinol; 2018 Oct; 267():167-171. PubMed ID: 29966658
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin and glucose homeostasis.
Delhanty PJ; van der Lely AJ
Peptides; 2011 Nov; 32(11):2309-18. PubMed ID: 21396419
[TBL] [Abstract][Full Text] [Related]
8. Treatment with the ghrelin-O-acyltransferase (GOAT) inhibitor GO-CoA-Tat reduces food intake by reducing meal frequency in rats.
Teuffel P; Wang L; Prinz P; Goebel-Stengel M; Scharner S; Kobelt P; Hofmann T; Rose M; Klapp BF; Reeve JR; Stengel A
J Physiol Pharmacol; 2015 Aug; 66(4):493-503. PubMed ID: 26348074
[TBL] [Abstract][Full Text] [Related]
9. Introducing GOAT: a target for obesity and anti-diabetic drugs?
Gualillo O; Lago F; Dieguez C
Trends Pharmacol Sci; 2008 Aug; 29(8):398-401. PubMed ID: 18606462
[TBL] [Abstract][Full Text] [Related]
10. Review of recent acetyl-CoA carboxylase inhibitor patents: mid-2007-2008.
Corbett JW
Expert Opin Ther Pat; 2009 Jul; 19(7):943-56. PubMed ID: 19552511
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin O-acyltransferase (GOAT) and energy metabolism.
Li Z; Mulholland M; Zhang W
Sci China Life Sci; 2016 Mar; 59(3):281-91. PubMed ID: 26732975
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ghrelin O-acyltransferase attenuates food deprivation-induced increases in ingestive behavior.
Teubner BJ; Garretson JT; Hwang Y; Cole PA; Bartness TJ
Horm Behav; 2013 Apr; 63(4):667-73. PubMed ID: 23399323
[TBL] [Abstract][Full Text] [Related]
13. Ghrelin acylation and metabolic control.
Al Massadi O; Tschöp MH; Tong J
Peptides; 2011 Nov; 32(11):2301-8. PubMed ID: 21893140
[TBL] [Abstract][Full Text] [Related]
14. Shedding light on the ghrelin/GOAT metabolism saga.
Garner AL; Janda KD
Chembiochem; 2011 Mar; 12(4):523-5. PubMed ID: 21254317
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin O-acyltransferase knockout mice show resistance to obesity when fed high-sucrose diet.
Kouno T; Akiyama N; Ito T; Okuda T; Nanchi I; Notoya M; Oka S; Yukioka H
J Endocrinol; 2016 Feb; 228(2):115-25. PubMed ID: 26645250
[TBL] [Abstract][Full Text] [Related]
16. A small molecule antagonist of ghrelin O-acyltransferase (GOAT).
Garner AL; Janda KD
Chem Commun (Camb); 2011 Jul; 47(26):7512-4. PubMed ID: 21594284
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides.
Yang J; Zhao TJ; Goldstein JL; Brown MS
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10750-5. PubMed ID: 18669668
[TBL] [Abstract][Full Text] [Related]
18. A new class of ghrelin O-acyltransferase inhibitors incorporating triazole-linked lipid mimetic groups.
Zhao F; Darling JE; Gibbs RA; Hougland JL
Bioorg Med Chem Lett; 2015 Jul; 25(14):2800-3. PubMed ID: 26009163
[TBL] [Abstract][Full Text] [Related]
19. Synthetic Triterpenoid Inhibition of Human Ghrelin O-Acyltransferase: The Involvement of a Functionally Required Cysteine Provides Mechanistic Insight into Ghrelin Acylation.
McGovern-Gooch KR; Mahajani NS; Garagozzo A; Schramm AJ; Hannah LG; Sieburg MA; Chisholm JD; Hougland JL
Biochemistry; 2017 Feb; 56(7):919-931. PubMed ID: 28134508
[TBL] [Abstract][Full Text] [Related]
20. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
Rao GS; Ramachandran MV; Bajaj JS
J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
